The North America Optical Coherence Tomography (OCT) Market would witness market growth of 8.2% CAGR during the forecast period (2022-2028).
OCT can now be used in various medical disciplines. The optical attenuation caused by tissue absorption and scattering limits the imaging depth. Yet, imaging can be accomplished in most tissues up to 2 - 3 mm deep. This scale is comparable to what traditional biopsies and histology generally image. In addition, OCT has a resolution 10–100 times greater than conventional clinical ultrasound. OCT has been used in vitro to image artery pathology and can distinguish between different plaque forms.
In vitro imaging research has also been carried out to look into potential uses in rheumatology, dermatology, gastrointestinal, urology, gynecology, surgery, and neurosurgery. OCT has also been used in vivo to examine biological specimens in development, including tadpoles and embryos from Rana pipiens, Xenopus laevis, and Brachyodanio rerio. OCT has potential uses in developmental biology since it makes it possible to repeatedly image-changing morphology without sacrificing specimens.
The rising prevalence of eye disorders, rising adoption of cutting-edge technologies like Fourier domain OCT systems in industrial and clinical applications, favorable government support, and the presence of top optical coherence tomography equipment manufacturers all contribute to the growth of the US optical coherence tomography market. Similarly, growing industrial applications for optical coherence tomography systems, such as industrial quality control and non-destructive testing, will increase the size of the region's optical coherence tomography (OCT) market. Advantageous medical insurance plans that help patients pay for their OCT treatments have also contributed to this technology's substantial share of the North American market. Hence, thereby boosting the market growth in North America.
The US market dominated the North America Optical Coherence Tomography (OCT) Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $555.1 million by 2028. The Canada market is poised to grow at a CAGR of 10.7% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 9.7% during (2022 - 2028).
Based on Type, the market is segmented into Handheld OCT Devices, Tabletop OCT Devices, and Catheter-based OCT. Based on End User, the market is segmented into Hospitals, Clinics, and Others. Based on Application, the market is segmented into Ophthalmology, Cardiovascular, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Optical Coherence Tomography (OCT) Market is Projected to reach USD 2.1 Billion by 2028, at a CAGR of 8.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Carl Zeiss AG, Danaher Corporation, Metall Zug AG (Haag-Streit AG), Nidek Co., Ltd., Thorlabs, Inc., Topcon Corporation, Agfa-Gevaert N.V. (IG arben), Heidelberg Engineering, Inc. (Heidelburg Engeneering GmbH), and Novacam Technologies Inc.
By Type
By End User
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
